Linvoseltamab (LINVO) plus bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial.


Por: Rodríguez-Otero, P, Delimpasi, S, Oriol, A, Dimopoulos, MA, Leleu, XP, Manier, S, Martinez-Chamorro, C, Chakraborty, R, Rubinstein, S, Sureda, A, Gonzalez, MS, Michot, JM, Breazna, A, Drew, J, Boyapati, A, Masinde, S, Kroog, GS, Sarkaria, SM and Martinez-Lopez, J

Publicada: 1 jun 2025
Resumen:


Filiaciones:
Manier, S:
 Lille Univ Hosp, Dept Hematol, Lille, France

Chakraborty, R:
 Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA

Rubinstein, S:
 Univ North Carolina, Dept Hematol Oncol, Durham, NC USA

Sureda, A:
 Univ Barcelona, Inst Catala Oncol LHospitalet, Clin Hematol Dept, IDIBELL, Barcelona, Spain

Gonzalez, MS:
 Complejo Hosp Univ Santiago Compostela, Dept Hematol, Serv Galego Saude, Santiago De Compostela, Spain

Michot, JM:
 Gustave Roussy Canc Campus, Villejuif, France

Breazna, A:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

Martinez-Lopez, J:
 CNIO Complutense Univ, Hosp Univ Octubre 12, Dept Hematol, Ciberonc,I 12, Madrid, Spain

Clin Univ Navarra, Dept Hematol, Pamplona, Spain
Gen Hosp Evangelismos, Dept Hematol & Bone Marrow Transplantat Unit, Athens, Greece
Inst Catala Oncol I Inst Josep Carreras Hosp Germa, Dept Hematol, Badalona, Spain
Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece
Univ Poitiers, CHU, Hematol, U1313,C 1082, Poitiers, France
Hosp Univ Quironsalud Madrid, Hematol Dept, Madrid, Spain
Univ Europea Madrid, Madrid, Spain
ISSN: 0732183X





JOURNAL OF CLINICAL ONCOLOGY
Editorial
American Society of Clinical Oncology, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 43 Número: 16_SUPPL
Páginas:
WOS Id: 001690254900011

MÉTRICAS